{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T03:09:03Z","timestamp":1775617743137,"version":"3.50.1"},"reference-count":29,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T00:00:00Z","timestamp":1600732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Orphan Technologies Ltd.","award":["AWD-111186 and AWD-182790"],"award-info":[{"award-number":["AWD-111186 and AWD-182790"]}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["16SDG30040000"],"award-info":[{"award-number":["16SDG30040000"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"name":"HCU Network North America and Australia","award":["research grant"],"award-info":[{"award-number":["research grant"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrients"],"abstract":"<jats:p>Albeit effective, methionine\/protein restriction in the management of classical homocystinuria (HCU) is suboptimal and hard to follow. To address unmet need, we developed an enzyme therapy (OT-58), which effectively corrected disease symptoms in various mouse models of HCU in the absence of methionine restriction. Here we evaluated short- and long-term efficacy of OT-58 on the background of current dietary management of HCU. Methionine restriction resulted in the lowering of total homocysteine (tHcy) by 38\u201363% directly proportional to a decreased methionine intake (50\u201312.5% of normal). Supplemental betaine resulted in additional lowering of tHcy. OT-58 successfully competed with betaine and normalized tHcy on the background of reduced methionine intake, while substantially lowering tHcy in mice on normal methionine intake. Betaine was less effective in lowering tHcy on the background of normal or increased methionine intake, while exacerbating hypermethioninemia. OT-58 markedly reduced both hyperhomocysteinemia and hypermethioninemia caused by the diets and betaine in HCU mice. Withdrawal of betaine did not affect improved metabolic balance, which was established and solely maintained by OT-58 during periods of fluctuating dietary methionine intake. Taken together, OT-58 may represent novel, highly effective enzyme therapy for HCU performing optimally in the presence or absence of dietary management of HCU.<\/jats:p>","DOI":"10.3390\/nu12092895","type":"journal-article","created":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T09:40:56Z","timestamp":1600767656000},"page":"2895","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Interplay of Enzyme Therapy and Dietary Management of Murine Homocystinuria"],"prefix":"10.3390","volume":"12","author":[{"given":"Insun","family":"Park","sequence":"first","affiliation":[{"name":"Section of Genetics and Metabolism, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erez M.","family":"Bublil","sequence":"additional","affiliation":[{"name":"Orphan Technologies Ltd., 8640 Rapperswil, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Glavin","sequence":"additional","affiliation":[{"name":"Orphan Technologies Ltd., 8640 Rapperswil, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2751-2124","authenticated-orcid":false,"given":"Tomas","family":"Majtan","sequence":"additional","affiliation":[{"name":"Section of Genetics and Metabolism, Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,9,22]]},"reference":[{"key":"ref_1","unstructured":"Scriver, C.R., Beaudet, A.L., Sly, W.S., Valle, D., Childs, B., Kinzler, K., and Vogelstein, B. (2001). Disorders of Transsulfuration. The Metabolic and Molecular Bases of Inherited Disease, McGraw-Hill. [8th ed.]."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Zuhra, K., Augsburger, F., Majtan, T., and Szabo, C. (2020). Cystathionine-beta-Synthase: Molecular Regulation and Pharmacological Inhibition. Biomolecules, 10.","DOI":"10.3390\/biom10050697"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10545-016-9979-0","article-title":"Guidelines for the diagnosis and management of cystathionine beta-synthase deficiency","volume":"40","author":"Morris","year":"2017","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1007\/PL00014308","article-title":"Strategies for the treatment of cystathionine \u03b2-synthase deficiency: The experience of the Willink Biochemical Genetics Unit over the past 30 years","volume":"157","author":"Walter","year":"1998","journal-title":"Eur. J. Pediatrics"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1021\/acs.biomac.7b00154","article-title":"Engineering and Characterization of an Enzyme Replacement Therapy for Classical Homocystinuria","volume":"18","author":"Majtan","year":"2017","journal-title":"Biomacromolecules"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5495","DOI":"10.1096\/fj.201700565R","article-title":"Enzyme replacement prevents neonatal death, liver damage, and osteoporosis in murine homocystinuria","volume":"31","author":"Majtan","year":"2017","journal-title":"FASEB J."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ymthe.2017.12.014","article-title":"Enzyme Replacement Therapy Ameliorates Multiple Symptoms of Murine Homocystinuria","volume":"26","author":"Majtan","year":"2018","journal-title":"Mol. Ther."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"12477","DOI":"10.1096\/fj.201901203R","article-title":"Behavior, body composition, and vascular phenotype of homocystinuric mice on methionine-restricted diet or enzyme replacement therapy","volume":"33","author":"Majtan","year":"2019","journal-title":"FASEB J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ymgme.2010.06.010","article-title":"A novel transgenic mouse model of CBS-deficient homocystinuria does not incur hepatic steatosis or fibrosis and exhibits a hypercoagulative phenotype that is ameliorated by betaine treatment","volume":"101","author":"Maclean","year":"2010","journal-title":"Mol. Genet. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1172\/JCI85396","article-title":"Enzyme replacement with PEGylated cystathionine beta-synthase ameliorates homocystinuria in murine model","volume":"126","author":"Bublil","year":"2016","journal-title":"J. Clin. Investig."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4939-3182-8_27","article-title":"Quantitation of S-Adenosylmethionine and S-Adenosylhomocysteine in Plasma Using Liquid Chromatography-Electrospray Tandem Mass Spectrometry","volume":"1378","author":"Arning","year":"2016","journal-title":"Methods Mol. Biol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/humu.23360","article-title":"Enzyme replacement therapy prevents loss of bone and fat mass in murine homocystinuria","volume":"39","author":"Majtan","year":"2018","journal-title":"Hum. Mutat."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/adc.41.220.666","article-title":"Dietary treatment of homocystinuria","volume":"41","author":"Komrower","year":"1966","journal-title":"Arch. Dis. Child."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1136\/adc.38.201.425","article-title":"Homocystinuria: A new inborn error of metabolism associated with mental deficiency","volume":"38","author":"Carson","year":"1963","journal-title":"Arch. Dis. Child."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0022-3476(81)80352-6","article-title":"The use of betaine for the treatment of homocystinuria","volume":"99","author":"Smolin","year":"1981","journal-title":"J. Pediatrics"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM198308253090802","article-title":"Homocystinuria-The effects of betaine in the treatment of patients not responsive to pyridoxine","volume":"309","author":"Wilcken","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1023\/A:1005445132327","article-title":"Homocystinuria due to cystathionine beta-synthase deficiency in Ireland-25 years experience of a newborn screened and treated population with reference to clinical outcome and biochemical control","volume":"21","author":"Yap","year":"1998","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s10545-015-9883-z","article-title":"Betaine supplementation is less effective than methionine restriction in correcting phenotypes of CBS deficient mice","volume":"39","author":"Gupta","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1517\/14712598.2015.963050","article-title":"Development of recombinant methioninase to target the general cancer-specific metabolic defect of methionine dependence: A 40-year odyssey","volume":"15","author":"Hoffman","year":"2015","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Gupta, S., and Kruger, W.D. (2011). Cystathionine beta-synthase deficiency causes fat loss in mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0027598"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4044","DOI":"10.1096\/fj.14-253633","article-title":"Altered hepatic sulfur metabolism in cystathionine beta-synthase-deficient homocystinuria: Regulatory role of taurine on competing cysteine oxidation pathways","volume":"28","author":"Jiang","year":"2014","journal-title":"FASEB J."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10545-006-0452-3","article-title":"A rationale for cystine supplementation in severe homocystinuria","volume":"30","author":"Lee","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ymgme.2006.02.004","article-title":"The use of betaine in the treatment of elevated homocysteine","volume":"88","author":"Levy","year":"2006","journal-title":"Mol. Genet. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/ajmg.10186","article-title":"Progressive cerebral edema associated with high methionine levels and betaine therapy in a patient with cystathionine beta-synthase (CBS) deficiency","volume":"108","author":"Yaghmai","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jpeds.2003.12.041","article-title":"Cerebral edema associated with betaine treatment in classical homocystinuria","volume":"144","author":"Devlin","year":"2004","journal-title":"J. Pediatrics"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.ymgme.2011.11.190","article-title":"Long-term betaine therapy in a murine model of cystathionine beta-synthase deficient homocystinuria: Decreased efficacy over time reveals a significant threshold effect between elevated homocysteine and thrombotic risk","volume":"105","author":"Maclean","year":"2012","journal-title":"Mol. Genet Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"6339","DOI":"10.1096\/fj.201802069RR","article-title":"Taurine alleviates repression of betaine-homocysteine S-methyltransferase and significantly improves the efficacy of long-term betaine treatment in a mouse model of cystathionine beta-synthase-deficient homocystinuria","volume":"33","author":"Maclean","year":"2019","journal-title":"FASEB J."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13023-019-1036-2","article-title":"Betaine anhydrous in homocystinuria: Results from the RoCH registry","volume":"14","author":"Valayannopoulos","year":"2019","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.biochi.2019.12.007","article-title":"Classical homocystinuria: From cystathionine beta-synthase deficiency to novel enzyme therapies","volume":"173","author":"Bublil","year":"2020","journal-title":"Biochimie"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/9\/2895\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T10:12:27Z","timestamp":1760177547000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/12\/9\/2895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,22]]},"references-count":29,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9]]}},"alternative-id":["nu12092895"],"URL":"https:\/\/doi.org\/10.3390\/nu12092895","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,22]]}}}